Barclays’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $106M | Buy |
|
|||||
|
2025
Q2 | $127M | Buy |
|
|||||
|
2025
Q1 | $99M | Buy |
|
|||||
|
2024
Q4 | $98.7M | Buy |
|
|||||
|
2024
Q3 | $80.8M | Sell |
|
|||||
|
2024
Q2 | $165M | Buy |
|
|||||
|
2024
Q1 | $178M | Buy |
|
|||||
|
2023
Q4 | $138M | Buy |
|
|||||
|
2023
Q3 | $95.3M | Buy |
|
|||||
|
2023
Q2 | $102M | Buy |
|
|||||
|
2023
Q1 | $48.8M | Sell |
|
|||||
|
2022
Q4 | $67.3M | Buy |
|
|||||
|
2022
Q3 | $36.4M | Buy |
|
|||||
|
2022
Q2 | $28.3M | Sell |
|
|||||
|
2022
Q1 | $77.8M | Sell |
|
|||||
|
2021
Q4 | $103M | Buy |
|
|||||
|
2021
Q3 | $103M | Buy |
|
|||||
|
2021
Q2 | $63.1M | Buy |
|
|||||
|
2021
Q1 | $47.6M | Sell |
|
|||||
|
2020
Q4 | $62.5M | Buy |
|
|||||
|
2020
Q3 | $49.3M | Buy |
|
|||||
|
2020
Q2 | $37.9M | Buy |
|
|||||
|
2020
Q1 | $8.7M | Sell |
|
|||||
|
2019
Q4 | $7.59M | Sell |
|
|||||
|
2019
Q3 | $5.78M | Sell |
|
|||||
|
2019
Q2 | $43.6M | Buy |
|
|||||
|
2019
Q1 | $4.89M | Sell |
|
|||||
|
2018
Q4 | $5.55M | Sell |
|
|||||
|
2018
Q3 | $9.39M | Buy |
|
|||||
|
2018
Q2 | $5.37M | Buy |
|
|||||
|
2018
Q1 | $1.28M | Sell |
|
|||||
|
2017
Q4 | $1.58M | Buy |
|
|||||
|
2017
Q3 | $409K | Sell |
|
|||||
|
2017
Q2 | $1.51M | Buy |
|
|||||
|
2017
Q1 | $1.07M | Sell |
|
|||||
|
2016
Q4 | $1.83M | Buy |
|
|||||
|
2016
Q3 | $806K | Sell |
|
|||||
|
2016
Q2 | $1.78M | Buy |
|
|||||
|
2016
Q1 | $279K | Sell |
|
|||||
|
2015
Q4 | $965K | Buy |
|
|||||
|
2015
Q3 | $547K | Buy |
|
|||||
|
2015
Q2 | $100K | Sell |
|
|||||
|
2015
Q1 | $140K | Sell |
|
|||||
|
2014
Q4 | $3.04M | Buy |
|
|||||
|
2014
Q3 | $101K | Buy |
|
|||||
|
2014
Q2 | $80K | Sell |
|
|||||
|
2014
Q1 | $122K | Sell |
|
|||||
|
2013
Q4 | $498K | Buy |
|
|||||
|
2013
Q3 | $306K | Buy |
|
|||||
|
2013
Q2 | $84K | Buy |
|